ArticleBritish journal of cancer2015
The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers.
Article in British journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
73 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Primary Care Referral Delays in Oral Cancer Diagnosis: A Meta-Analysis.Oral diseases · 2025Pooled it
- The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis.PLoS medicine · 2022Pooled it
- The influence of health literacy on the timely diagnosis of symptomatic cancer: A systematic review.European journal of cancer care · 2019Pooled it
- Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis.BMJ open · 2018Pooled it
- Patient involvement in diagnosing cancer in primary care: a systematic review of current interventions.The British journal of general practice : the journal of the Royal College of General Practitioners · 2018Pooled it
- Pooled it
- Trial
- Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study.BMC cancer · 2017Trial
- Bridging the difficult talk: dentists' perception of a patient-centred communication aid to improve oral cancer early detection.BMC oral health · 2026Article
- Article
- Article
- The role of social inequalities in the epidemiology of urological cancers: can this inform cancer screening?Annals of the Royal College of Surgeons of England · 2026Article
- Diagnostic Delay in Soft Tissue Sarcomas: A Review.Cancers · 2025Review
- Just how many diagnostic errors and harms are out there, really? It depends on how you count.BMJ quality & safety · 2025Article
- Oesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey.British journal of cancer · 2024Article
- Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients.Future oncology (London, England) · 2024Article
- Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis.Cancers · 2023Article
- Talking about cancer: Patient responses to raising awareness of oral cancer in primary dental care.Community dentistry and oral epidemiology · 2023Article
- Article
- Article
13 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAppreciating variation in the length of pre- or post-presentation diagnostic intervals can help prioritise early diagnosis interventions with either a community or a primary care focus.
methodsWe analysed data from the first English National Audit of Cancer Diagnosis in Primary Care on 10 953 patients with any of 28 cancers. We calculated summary statistics for the length of the patient and the primary care interval and their ratio, by cancer site.
resultsInterval lengths varied greatly by cancer. Laryngeal and oropharyngeal cancers had the longest median patient intervals, whereas renal and bladder cancer had the shortest (34.5 and 30 compared with 3 and 2 days, respectively). Multiple myeloma and gallbladder cancer had the longest median primary care intervals, and melanoma and breast cancer had the shortest (20.5 and 20 compared with 0 and 0 days, respectively). Mean patient intervals were longer than primary care intervals for most (18 of 28) cancers, and notably so (two- to five-fold greater) for 10 cancers (breast, melanoma, testicular, vulval, cervical, endometrial, oropharyngeal, laryngeal, ovarian and thyroid).
conclusionsThe findings support the continuing development and evaluation of public health interventions aimed at shortening patient intervals, particularly for cancers with long patient interval and/or high patient interval over primary care interval ratio.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.